Evolus Inc [EOLS] stock is trading at $17.24, up 2.01%. An important factor to consider is whether the stock is rising or falling in short-term value. The EOLS shares have gain 4.55% over the last week, with a monthly amount drifted -1.43%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Evolus Inc [NASDAQ: EOLS] stock has seen the most recent analyst activity on January 29, 2024, when Barclays upgraded its rating to a Overweight and also boosted its price target to $16 from $10. Previously, Needham started tracking the stock with Buy rating on June 23, 2022, and set its price target to $18. On May 12, 2022, upgrade upgraded it’s rating to Equal Weight and revised its price target to $10 on the stock. Truist upgraded its rating to a Buy but stick to its price target of $11 on January 20, 2022. Mizuho upgraded its rating to a Buy but $15 remained the price target by the analyst firm on May 06, 2021. H.C. Wainwright reiterated a Buy rating for this stock on April 08, 2021, and upped its price target to $22. In a note dated February 24, 2021, Truist downgraded an Hold rating on this stock but restated the target price of $12.
Evolus Inc [EOLS] stock has fluctuated between $7.44 and $17.70 over the past year. Currently, Wall Street analysts expect the stock to reach $24 within the next 12 months. Evolus Inc [NASDAQ: EOLS] shares were valued at $17.24 at the most recent close of the market. An investor can expect a potential return of 39.21% based on the average EOLS price forecast.
Analyzing the EOLS fundamentals
Evolus Inc [NASDAQ:EOLS] reported sales of 237.26M for the trailing twelve months, which represents a growth of 35.59%. Gross Profit Margin for this corporation currently stands at 0.68% with Operating Profit Margin at -0.14%, Pretax Profit Margin comes in at -0.22%, and Net Profit Margin reading is -0.22%. To continue investigating profitability, this company’s Return on Assets is posted at -0.23, Equity is 92.54 and Total Capital is -0.18. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 6.31.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 16.70 points at the first support level, and at 16.16 for the second support level. However, for the 1st resistance point, the stock is sitting at 17.80, and for the 2nd resistance point, it is at 18.36.
Ratios To Look Out For
For context, Evolus Inc’s Current Ratio is 2.92. On the other hand, the Quick Ratio is 2.67, and the Cash Ratio is 1.73. Considering the valuation of this stock, the price to sales ratio is 4.58, the price to book ratio is 56.28.
Transactions by insiders
Recent insider trading involved Beaver Sandra, Chief Financial Officer, that happened on Sep 06 ’24 when 3276.0 shares were sold. Chief Marketing Officer, Yamagishi-Dressler Tomoko completed a deal on Aug 30 ’24 to sell 5631.0 shares. Meanwhile, MOATAZEDI DAVID sold 0.18 million shares on Jun 06 ’24.
